Progress Update, Future Vision

Now coming into the final year of its first three-year phase, this federal initiative has been largely successful but has also uncovered some major challenges.  Gain actionable insight on what’s next to help you:

• Analyze how well the bilateral agreements are working between the federal, provincial and territorial governments
• Understand where deficiencies still exist that need targeted funding
• Determine how Canada’s rare disease strategy ranks as measured against those of other countries in delivering access to treatment
• Position your organization for Phase 2 of the national strategy beyond 2027

Gain insight to identify key areas that will be targeted as this initiative moves toward Phase 2.